ScholarIQanswers from OpenAlex & ORCID
Vassiliki A. Papadimitrakopoulou
ResearcherPublications, citations & collaboration network
Vassiliki A. Papadimitrakopoulou is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vassiliki A. Papadimitrakopoulou have?
ScholarIQindexed works
Vassiliki A. Papadimitrakopoulou has 530 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vassiliki A. Papadimitrakopoulou have?
ScholarIQcitation count
Vassiliki A. Papadimitrakopoulou has 27,608 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vassiliki A. Papadimitrakopoulou?
ScholarIQh-index
Vassiliki A. Papadimitrakopoulou has an h-index of 82 in OpenAlex.
What is the i10-index of Vassiliki A. Papadimitrakopoulou?
ScholarIQi10-index
Vassiliki A. Papadimitrakopoulou has an i10-index of 186 in OpenAlex.
What is the ORCID of Vassiliki A. Papadimitrakopoulou?
ScholarIQorcid
The ORCID for Vassiliki A. Papadimitrakopoulou is on the source record.
What is the OpenAlex record for Vassiliki A. Papadimitrakopoulou?
ScholarIQopenalex
The OpenAlex for Vassiliki A. Papadimitrakopoulou is on the source record.
What are the most-cited papers on Vassiliki A. Papadimitrakopoulou?
ScholarIQmost cited works
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
Tony Mok, Yi‐Long Wu, Myung‐Ju Ahn, Marina Chiara Garassino, Hye Ryun Kim, Suresh S. Ramalingam, Frances A. Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S.M.E. Theelen, Chee Khoon Lee, Martin Sebastian, Alison Templeton, Helen Mann, Marcelo Marotti, Serban Ghiorghiu, Vassiliki A. Papadimitrakopoulou
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez Canales, Jianjun Zhang, Uma Giri, Jayanthi Gudikote, María Angélica Cortez, Chao Yang, You-Hong Fan, Michael Peyton, Luc Girard, Kevin R. Coombes, Carlo Toniatti, Timothy P. Heffernan, Murim Choi, Garrett M. Frampton, Vincent A. Miller, John N. Weinstein, Roy S. Herbst, Kwok‐Kin Wong, Jianhua Zhang, Padmanee Sharma, Gordon B. Mills, Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba, J. Jack Lee, George R. Blumenschein, Anne S. Tsao, David J. Stewart, Marshall E. Hicks, Jeremy J. Erasmus, Sanjay Gupta, Christine Alden, Suyu Liu, Ximing Tang, Fadlo R. Khuri, Hai T. Tran, Bruce E. Johnson, John V. Heymach, Li Mao, Frank V. Fossella, Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Suzanne E. Davis, Scott M. Lippman, Waun Ki Hong
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman, Heather A. Wakelee, Shirish M. Gadgeel, Andréa Varga, Vassiliki A. Papadimitrakopoulou, Benjamin Solomon, Geoffrey R. Oxnard, Rafał Dziadziuszko, Dara L. Aisner, Robert C. Doebele, Cathy Galasso, Edward B. Garon, Rebecca S. Heist, Jennifer Logan, Joel W. Neal, Melody Mendenhall, Suzanne Nichols, Zofia Piotrowska, Antoinette J. Wozniak, Mitch Raponi, Chris Karlovich, Sarah Jaw‐Tsai, Jeffrey D. Isaacson, Darrin Despain, Shannon Matheny, Lindsey Rolfe, Andrew R. Allen, D. Ross Camidge